Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 7/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.54 |
| ▸ | RAB9A | P51151 | 3/20 | 0.54 |
| ▸ | NPC1 | O15118 | 2/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | CASP3 | P42574 | 1/20 | 0.54 |
| ▸ | HBB | P68871 | 1/20 | 0.54 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.54 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.54 |
| ▸ | MAOA | P21397 | 3/20 | 0.53 |
| ▸ | MAOB | P27338 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 6/20 | 0.50 |
| ▸ | MEN1 | O00255 | 5/20 | 0.50 |
| ▸ | POLB | P06746 | 5/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.50 |
| ▸ | LMNA | P02545 | 3/20 | 0.50 |
| ▸ | THRB | P10828 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11648905 | 0.83 | MEN1 (0.46) | MAPK1SMN1; SMN2ALDH1A1L3MBTL1RAB9A | |
| SCHEMBL29940221 | 0.82 | POLB (0.63) | MAPK1SMN1; SMN2ALDH1A1L3MBTL1RAB9A | |
| SCHEMBL11131632 | 0.82 | POLB (0.63) | MAPK1SMN1; SMN2ALDH1A1L3MBTL1RAB9A | |
| SCHEMBL10781791 | 0.81 | MAPT (0.62) | MAPK1SMN1; SMN2ALDH1A1L3MBTL1RAB9A | |
| SCHEMBL28287515 | 0.81 | ADORA2A (0.58) | MAPK1SMN1; SMN2ALDH1A1L3MBTL1RAB9A | |
| SCHEMBL27496947 | 0.79 | MAOA (0.53) | MAPK1SMN1; SMN2ALDH1A1L3MBTL1RAB9A | |
| Methylamine SCHEMBL10780560 | 0.79 | ADORA2A (0.56) | MAPK1SMN1; SMN2ALDH1A1L3MBTL1RAB9A | |
| SCHEMBL6390809 | 0.79 | P2RY4 (0.46) | MAPK1SMN1; SMN2L3MBTL1RAB9ANPC1 | |
| SCHEMBL14582002 | 0.77 | POLB (0.56) | MAPK1SMN1; SMN2ALDH1A1L3MBTL1RAB9A | |
| SCHEMBL6372565 | 0.76 | NSD2 (0.58) | MAPK1SMN1; SMN2ALDH1A1L3MBTL1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110035739-B | Dye composition comprising 12-hydroxystearic acid, an organic amine and a dye | 欧莱雅 | 2022-05-10 | — | — | CN | disclosed |
| EP-3883539-A1 | AZOMETHINE DYE CHROMOPHORES | BASF SE (DE) | 2021-09-29 | — | — | EP | disclosed |
| US-20100005600-A1 | PROCESS FOR TREATING KERATIN FIBRES BY APPLYING HEAT | L'OREAL S.A. | 2010-01-14 | — | — | US | disclosed |
| US-7608115-B2 | Process for treating keratin fibres by applying heat | L'OREAL S.A. (FR) | 2009-10-27 | — | — | US | disclosed |
| US-20070174974-A1 | Process for treating keratin fibres by applying heat | L'OREAL S.A. (FR) | 2007-08-02 | — | — | US | disclosed |
| EP-1631241-A1 | PROCESS FOR TREATING KERATIN FIBRES BY APPLYING HEAT | L'OREAL (FR) | 2006-03-08 | — | — | EP | disclosed |
| WO-2004098550-A1 | PROCESS FOR TREATING KERATIN FIBRES BY APPLYING HEAT | L'OREAL (FR) | 2004-11-18 | — | — | WO | disclosed |
| US-4695653-A | Cationic surface-active agents | L'OREAL (FR) | 1987-09-22 | — | — | US | disclosed |
| US-4436909-A | HAIR COSMETICS | L'OREAL (FR) | 1984-03-13 | — | — | US | disclosed |
| US-4220602-A | FOR HAIR COSMETICS | L'OREAL (FR) | 1980-09-02 | — | — | US | disclosed |
| US-4096332-A | POLYHYDROXYLATED TERTIARY AMINES OR QUATERNARY AMMONIUM SALTS THEREOF | L'OREAL (FR) | 1978-06-20 | — | — | US | disclosed |
| US-4009255-A | POLYHYDROXYLATED TERTIARY AMINES | SOCIETE ANONYME DITE: L'OREAL (FR) | 1977-02-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100005600-A1 | PROCESS FOR TREATING KERATIN FIBRES BY APPLYING HEAT | KRT18, FECH, HSPD1 | MAPK1 2556/4885SMN1; SMN2 4800/4885ALDH1A1 866/4885 |
| US-20070174974-A1 | Process for treating keratin fibres by applying heat | KRT18, FECH, HSPD1 | MAPK1 2556/4885SMN1; SMN2 4800/4885ALDH1A1 866/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.